Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1997-04-18
1998-09-22
Kight, John
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514844, 514912, 514914, 5483391, A01N 4350, C07D23360
Patent
active
058114467
ABSTRACT:
The present invention relates to methods for protecting the eye from degenerative eye conditions by administering prophylactic histidine compositions. The invention also relates to methods for treating ocular inflammation resulting from various causative agents, by administering therapeutic histidine compositions. The invention relates further still to novel histidine compositions for carrying out the present methods.
REFERENCES:
Babizhayev, Biochimica et Biophysica Acta vol. 1004, "Antioxidant activity of L-carnosine, a natural histidine-containing dipeptide in crystalline lens", pp. 363-371, (1989).
Babizhayev, Chemical Abstract vol. 111 No. 167340, "Antioxidant activity of L-carnosne, a natural histidine" (1989).
Santen et al, Chemical abstract vol. 98 No. 149604, "Eye lotions containing an antinflammatory ketopropen" (1983).
Angres Isaac A.
Covington Raymond
Cytos Pharmaceuticals LLC
Kight John
Petraglia Susan P.
LandOfFree
Prophylactic and therapeutic methods for ocular degenerative dis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Prophylactic and therapeutic methods for ocular degenerative dis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Prophylactic and therapeutic methods for ocular degenerative dis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1622110